RecruitingNCT06911931
Visual Perception in Schizophrenia
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In RochesterSchizophrenia, BipolarityOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT06906003
Visual Rehabilitation and Depression in Visually Impaired people with AMD
This study is recruiting. It focuses on depression and currently lists participation information in Italy.
In RomeDepression, AnxietyOtherOver 55 Years
RecruitingISRCTN44890666
VITAL Germany (Valdoxan® Improves Treatment of depression and daytime Activity in real Life)
This study is recruiting. It focuses on depression and currently lists participation information in Germany.
In GermanyDepressionOther
RecruitingISRCTN70909899
Vitamin D and non-specific musculoskeletal complaints in non-Western immigrants
This study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsDepressionOtherFrom 18 Years to 60 Years
RecruitingISRCTN12424842
Vitamin D supplementation compared to placebo in people presenting with their first episode of psychosis neuroprotection design
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomSchizophreniaOtherFrom 18 Years to 65 Years
RecruitingISRCTN18801971
VIVALDI Praxis: Valdoxan improves depressive symptoms and normalizes circadian rhythms
This study is recruiting. It focuses on depression and currently lists participation information in Germany.
In GermanyDepressionOther
RecruitingISRCTN49411996
VIVALDI: Valdoxan® improves depressive symptoms and normalises circadian rhythms
This study is recruiting. It focuses on depression and currently lists participation information in Germany.
In GermanyDepressionOtherOver 18 Years
RecruitingNCT06613334
Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
Multiple locations, including ParisSchizophreniaOtherFrom 18 Years to 60 Years
RecruitingNCT06835556
Volatility in Paranoia (VIP) study: An RCT of Changes in Volatility With Psychotherapy
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In NashvilleSchizophreniaOtherFrom 18 Years to 65 Years
RecruitingNCT07633626
Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib
This study is recruiting. It focuses on depression and currently lists participation information in Colombia.
In BogotáDepressionOtherOver 18 Years
RecruitingNCT07579481
Vortioxetine in Depression and Concomitant Migraine
This study is recruiting. It focuses on depression and currently lists participation information in Italy.
In RomeDepressionOtherOver 18 Years
RecruitingISRCTN72046738
VP3: Vancouver primary prevention project (anxiety disorders prevention in school children)
This study is recruiting. It focuses on anxiety and currently lists participation information in Canada.
In CanadaAnxietyOtherFrom 5 Years to 11 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.